Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development

Aim of the research – to assess the clinical and laboratory parameters in patients with chronic hepatitis C (CHC) on the early stages of development and their comparison with the level of galectin3. The study included 78 patients with oligosymptomatic course of the disease and minimal liver fibrosis...

Full description

Bibliographic Details
Main Authors: N. S. Zhevnerova, T. V. Antonova, V. A. Kovaleva
Format: Article
Language:Russian
Published: Academician I.P. Pavlov First St. Petersburg State Medical University 2016-12-01
Series:Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
Subjects:
Online Access:https://www.sci-notes.ru/jour/article/view/357
_version_ 1826560777174122496
author N. S. Zhevnerova
T. V. Antonova
V. A. Kovaleva
author_facet N. S. Zhevnerova
T. V. Antonova
V. A. Kovaleva
author_sort N. S. Zhevnerova
collection DOAJ
description Aim of the research – to assess the clinical and laboratory parameters in patients with chronic hepatitis C (CHC) on the early stages of development and their comparison with the level of galectin3. The study included 78 patients with oligosymptomatic course of the disease and minimal liver fibrosis in the most cases. In the most patients with stages of the disease exceeding 8 years, viral load was over a million copies/ml. In 10 % of patients on the early stages of the disease, changes corresponding to severe liver fibrosis and cirrhosis F3 and F4 were detected. Moderate correlation of ALT activity, viral load and low severity with the duration of the disease was identified. There is a trend towards a higher level of galectin3 in a long course of CHC in comparison with earlier stages of its development, with significantly higher average level of galectin-3 in patients with minimal liver fibrosis (F0–F1) as compared to advanced stages, suggesting its importance in the launching and initial mechanisms of fibrogenesis.
first_indexed 2024-03-12T03:41:14Z
format Article
id doaj.art-01f1bf198e7e4280a06ed96ae29266a8
institution Directory Open Access Journal
issn 1607-4181
2541-8807
language Russian
last_indexed 2025-03-14T09:21:40Z
publishDate 2016-12-01
publisher Academician I.P. Pavlov First St. Petersburg State Medical University
record_format Article
series Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
spelling doaj.art-01f1bf198e7e4280a06ed96ae29266a82025-03-02T11:44:13ZrusAcademician I.P. Pavlov First St. Petersburg State Medical UniversityУчёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова1607-41812541-88072016-12-01234455910.24884/1607-4181-2016-23-4-45-59317Clinical and laboratory characteristics of chronic hepatitis C on the early stages of developmentN. S. Zhevnerova0T. V. Antonova1V. A. Kovaleva2Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. ПавловаПервый Санкт-Петербургский государственный медицинский университет имени академика И.П. ПавловаПервый Санкт-Петербургский государственный медицинский университет имени академика И.П. ПавловаAim of the research – to assess the clinical and laboratory parameters in patients with chronic hepatitis C (CHC) on the early stages of development and their comparison with the level of galectin3. The study included 78 patients with oligosymptomatic course of the disease and minimal liver fibrosis in the most cases. In the most patients with stages of the disease exceeding 8 years, viral load was over a million copies/ml. In 10 % of patients on the early stages of the disease, changes corresponding to severe liver fibrosis and cirrhosis F3 and F4 were detected. Moderate correlation of ALT activity, viral load and low severity with the duration of the disease was identified. There is a trend towards a higher level of galectin3 in a long course of CHC in comparison with earlier stages of its development, with significantly higher average level of galectin-3 in patients with minimal liver fibrosis (F0–F1) as compared to advanced stages, suggesting its importance in the launching and initial mechanisms of fibrogenesis.https://www.sci-notes.ru/jour/article/view/357chronic hepatitis cgalectin-3liver fibrosis
spellingShingle N. S. Zhevnerova
T. V. Antonova
V. A. Kovaleva
Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
chronic hepatitis c
galectin-3
liver fibrosis
title Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
title_full Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
title_fullStr Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
title_full_unstemmed Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
title_short Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
title_sort clinical and laboratory characteristics of chronic hepatitis c on the early stages of development
topic chronic hepatitis c
galectin-3
liver fibrosis
url https://www.sci-notes.ru/jour/article/view/357
work_keys_str_mv AT nszhevnerova clinicalandlaboratorycharacteristicsofchronichepatitiscontheearlystagesofdevelopment
AT tvantonova clinicalandlaboratorycharacteristicsofchronichepatitiscontheearlystagesofdevelopment
AT vakovaleva clinicalandlaboratorycharacteristicsofchronichepatitiscontheearlystagesofdevelopment